The estimated Net Worth of Scott Mendel is at least $16.7 Миллион dollars as of 25 January 2021. Mr. Mendel owns over 64,975 units of GenMark Diagnostics Inc stock worth over $11,491,793 and over the last 11 years he sold GNMK stock worth over $3,496,376. In addition, he makes $1,749,300 as President, Chief Executive Officer и Director at GenMark Diagnostics Inc.
Sign up
Mr. Mendel GNMK stock SEC Form 4 insiders trading
Scott has made over 60 trades of the GenMark Diagnostics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 64,975 units of GNMK stock worth $924,594 on 25 January 2021.
The largest trade he's ever made was exercising 146,172 units of GenMark Diagnostics Inc stock on 19 January 2021 worth over $3,513,975. On average, Scott trades about 7,658 units every 28 days since 2014. As of 25 January 2021 he still owns at least 478,028 units of GenMark Diagnostics Inc stock.
You can see the complete history of Mr. Mendel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Scott Mendel biography
Scott Mendel serves as President, Chief Executive Officer, Director of the Company. Mr. Mendel previously served as the Company’s Chief Operating Officer from February 2019 to February 2020. Prior to serving as the Company’s Chief Operating Officer, Mr. Mendel served as the Company’s Chief Financial Officer from May 2014 to February 2019. Prior to joining the Company, Mr. Mendel served as the Chief Financial Officer of The Active Network, Inc., a global software as a service (SaaS) company that provides technology to organizers of events and activities, from March 2010 through its acquisition by the private-equity firm Vista Equity Partners in December 2013. Prior to joining The Active Network, Mr. Mendel held finance positions at General Electric, a diversified technology, media and financial services company, for over 20 years, including chief financial officer from March 2003 to March 2010 for General Electric’s Healthcare IT division, a leading provider of medical technologies and services. Mr. Mendel earned a B.S. in finance from Indiana University and an M.B.A. from Northwestern University’s Kellogg School of Management.
What is the salary of Scott Mendel?
As the President, Chief Executive Officer и Director of GenMark Diagnostics Inc, the total compensation of Scott Mendel at GenMark Diagnostics Inc is $1,749,300. There are no executives at GenMark Diagnostics Inc getting paid more.
How old is Scott Mendel?
Scott Mendel is 53, he's been the President, Chief Executive Officer и Director of GenMark Diagnostics Inc since 2020. There are 4 older and 5 younger executives at GenMark Diagnostics Inc. The oldest executive at GenMark Diagnostics Inc is Daryl Faulkner, 71, who is the Independent Director.
Insiders trading at GenMark Diagnostics Inc
Over the last 14 years, insiders at GenMark Diagnostics Inc have traded over $27,572,889 worth of GenMark Diagnostics Inc stock and bought 454,838 units worth $2,182,328 . The most active insiders traders include Hany Massarany, Jon Faiz Kayyem и Kevin C Oboyle. On average, GenMark Diagnostics Inc executives and independent directors trade stock every 5 days with the average trade being worth of $141,403. The most recent stock trade was executed by Michael Gleeson on 14 April 2021, trading 27,667 units of GNMK stock currently worth $326,471.
What does GenMark Diagnostics Inc's logo look like?
Complete history of Mr. Mendel stock trades at GenMark Diagnostics Inc
GenMark Diagnostics Inc executives and stock owners
GenMark Diagnostics Inc executives and other stock owners filed with the SEC include:
-
Scott Mendel,
President, Chief Executive Officer, Director -
Johnny Ek,
Chief Financial Officer -
Michael Gleeson,
Senior Vice President, Corporate Accounts -
Eric Stier,
Senior Vice President, General Counsel, Secretary -
James Fox,
Non-Executive Independent Director -
Kevin O'Boyle,
Independent Chairman of the Board -
Lisa Giles,
Independent Director -
Daryl Faulkner,
Independent Director -
Michael Kagnoff,
Independent Director -
Tyler Jensen,
Senior Vice President - Engineering and Product Technical Support -
Jon Faiz Kayyem,
President & CEO -
Jennifer Anne Williams,
SVP Global Operations -
Wade R. Stevenson,
SVP, North America Sales -
Brian Andrew Mitchell,
SVP, Operations -
Christine Shaw,
VP, Assay Development -
John Frederick Ek,
Chief Financial Officer -
Richard B Slansky,
Chief Financial Officer -
Stephen T Worland,
Director -
Jeffrey Alan Hawkins,
SVP, Marketing & Bus Dev -
Ingo Chakravarty,
SVP, International -
Christopher M Gleeson,
Director -
James B. Mc Nally,
SVP, Marketing and Bus. Dev. -
Jorge Garces,
SVP, Research & Development -
Paul Ross,
CFO & Secretary -
Pankaj Singhal,
Sr. VP, Product Dev & Mftg -
Matthew Robert Cohen,
SVP, Gen Counsel & Secretary -
John Bellano,
SR. VP, Commercial Operations -
Steven J Kemper,
CFO, Treasurer & Secretary -
Bradley Calvin,
Senior VP, Global Marketing -
Scott Alexander O'brien,
SVP, Global Mktg & Int'l Sales -
Hany Massarany,
President and CEO -
Sarah Hollis Winkler,
VP, Human Resources -
Alan Baer Maderazo,
VP, Qual, Reg, & Clin Affairs -
Michael John Harkins,
SVP, Sales -
Abdul Chohan,
SVP Operations